Company / Operating Income
PULSE BIOSCIENCES, INC. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$76.9M
FY2025
5-year range
-$76.9M / -$56.3M
FY2021-FY2025
Trend
-36.8%
vs FY2024
Sector context
#126 of 156
Health Care
What the data says
PULSE BIOSCIENCES, INC.'s operating income of -$77M is lower than 81% of companies in the Health Care sector (FY2025). Declined from -$58M to -$77M over the past 2 years.
Based on SEC 10-K filings.
-$77M in FY2025.
Declined from -$58M to -$77M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 156This company -$76.9M Sector average $733.1M
▼
-110.5% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 36.8% year-over-year.
- Ranks #126 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$76.9M | -36.8% |
| FY2024 | -$56.3M | +3.1% |
| FY2023 | -$58.1M | +0.0% |
| FY2022 | -$58.1M | +7.9% |
| FY2021 | -$63.0M | -26.1% |
| FY2020 | -$50.0M | -4.2% |
| FY2019 | -$48.0M | -27.7% |
| FY2018 | -$37.5M | -46.8% |
| FY2017 | -$25.6M | -168.6% |
| FY2016 | -$9.5M | -113.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026